Pranjali Kanvinde

416 total citations
9 papers, 307 citations indexed

About

Pranjali Kanvinde is a scholar working on Surgery, Genetics and Urology. According to data from OpenAlex, Pranjali Kanvinde has authored 9 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Genetics and 2 papers in Urology. Recurrent topics in Pranjali Kanvinde's work include Nanoparticle-Based Drug Delivery (2 papers), Urinary and Genital Oncology Studies (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Pranjali Kanvinde is often cited by papers focused on Nanoparticle-Based Drug Delivery (2 papers), Urinary and Genital Oncology Studies (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Pranjali Kanvinde collaborates with scholars based in United States, Pakistan and Russia. Pranjali Kanvinde's co-authors include Deo R. Singh, Christopher King, Abhijit A. Date, Laura M. Ensign, Elena B. Pasquale, Kalina Hristova, Justin Hanes, Anthony J. Kim, Jeffrey A. Winkles and Pavlos Anastasiadis and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Langmuir.

In The Last Decade

Pranjali Kanvinde

8 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pranjali Kanvinde United States 8 97 63 62 55 48 9 307
Miltiadis Fiorentzis Germany 11 58 0.6× 39 0.6× 21 0.3× 94 1.7× 17 0.4× 50 365
Lilach Koren Israel 12 174 1.8× 46 0.7× 16 0.3× 88 1.6× 23 0.5× 22 408
Irfan Ullah United States 10 144 1.5× 61 1.0× 51 0.8× 58 1.1× 9 0.2× 25 301
Mohamed Mashal Spain 13 392 4.0× 87 1.4× 143 2.3× 58 1.1× 31 0.6× 21 564
Deepak Kumar Sahel India 12 182 1.9× 64 1.0× 32 0.5× 56 1.0× 11 0.2× 22 303
Katie F. Maass United States 12 212 2.2× 27 0.4× 45 0.7× 43 0.8× 8 0.2× 23 614
Qurrat Ul Ain South Korea 10 249 2.6× 30 0.5× 19 0.3× 37 0.7× 9 0.2× 16 388
Tomofumi Kurokawa Japan 11 154 1.6× 46 0.7× 75 1.2× 32 0.6× 13 0.3× 21 412
Siyuan Hou China 11 159 1.6× 52 0.8× 19 0.3× 96 1.7× 11 0.2× 17 430
Giorgia Urbinati France 14 307 3.2× 43 0.7× 10 0.2× 25 0.5× 49 1.0× 16 459

Countries citing papers authored by Pranjali Kanvinde

Since Specialization
Citations

This map shows the geographic impact of Pranjali Kanvinde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pranjali Kanvinde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pranjali Kanvinde more than expected).

Fields of papers citing papers by Pranjali Kanvinde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pranjali Kanvinde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pranjali Kanvinde. The network helps show where Pranjali Kanvinde may publish in the future.

Co-authorship network of co-authors of Pranjali Kanvinde

This figure shows the co-authorship network connecting the top 25 collaborators of Pranjali Kanvinde. A scholar is included among the top collaborators of Pranjali Kanvinde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pranjali Kanvinde. Pranjali Kanvinde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pandey, Nikhil, Anshika Kapur, Pavlos Anastasiadis, et al.. (2025). Fn14-Targeted Gold Nanorods for Augmenting Laser Thermal Therapy for High-Grade Gliomas. Langmuir. 41(28). 18520–18531.
2.
Pandey, Nikhil, Pavlos Anastasiadis, Pranjali Kanvinde, et al.. (2022). Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment. Advanced Drug Delivery Reviews. 188. 114415–114415. 46 indexed citations
3.
Kanvinde, Pranjali, Pratikkumar Patel, Hiwa K. Saeed, et al.. (2021). An ion‐paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection. Bioengineering & Translational Medicine. 6(3). e10238–e10238. 26 indexed citations
4.
Kanvinde, Pranjali, Adarsha P. Malla, Nina P. Connolly, et al.. (2021). Leveraging the replication‐competent avian‐like sarcoma virus/tumor virus receptor‐A system for modeling human gliomas. Glia. 69(9). 2059–2076. 12 indexed citations
5.
Date, Abhijit A., Max Kates, Takahiro Yoshida, et al.. (2020). Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer. Drug Delivery and Translational Research. 11(5). 2085–2095. 8 indexed citations
6.
Date, Abhijit A., Gilad Halpert, Pranjali Kanvinde, et al.. (2018). Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease. Biomaterials. 185. 97–105. 84 indexed citations
7.
Singh, Deo R., Pranjali Kanvinde, Christopher King, Elena B. Pasquale, & Kalina Hristova. (2018). The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures. Communications Biology. 1(1). 15–15. 66 indexed citations
8.
Kates, Max, Abhijit A. Date, Takahiro Yoshida, et al.. (2017). Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non–Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 23(21). 6592–6601. 47 indexed citations
9.
Date, Abhijit A., Rana Rais, Pranjali Kanvinde, et al.. (2017). Local enema treatment to inhibit FOLH1 /GCPII as a novel therapy for inflammatory bowel disease. Journal of Controlled Release. 263. 132–138. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026